Letter to Stakeholders Regarding the Implementation of Safety Features Under the Falsified Medicines Directive 2011/62/UE

Letter to Stakeholders Regarding the Implementation of Safety Features Under the Falsified Medicines Directive 2011/62/UE

Letter-to-stakeholders-on-obligations_17.10.2018